Agios Pharma to discontinue sickle cell disease treatment development
AGIO•Agios ends sickle cell treatment program
Agios Pharmaceuticals AGIO.O said on Tuesday it will stop development of its sickle cell disease treatment after results from a mid-stage trial did not establish a differentiated profile to support continued development.
